Braidwell LP Deciphera Pharmaceuticals, Inc. Transaction History

Braidwell LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$13.58 - $17.36 $7.6 Million - $9.72 Million	-559,847 Reduced 47.87%	609,643 $9.59 Billion
Q4 2023 Feb 14, 2024	SELL	$10.11 - $16.54 $21.9 Million - $35.8 Million	-2,166,731 Reduced 64.95%	1,169,490 $18.9 Billion
Q3 2023 Nov 14, 2023	SELL	$12.46 - $15.48 $3.87 Million - $4.8 Million	-310,198 Reduced 8.51%	3,336,221 $42.4 Billion
Q2 2023 Aug 14, 2023	BUY	$13.28 - $15.96 $5.38 Million - $6.46 Million	405,068 Added 12.5%	3,646,419 $51.3 Billion
Q1 2023 May 15, 2023	SELL	$14.26 - $22.1 $430,110 - $666,580	-30,162 Reduced 0.92%	3,241,351 $50.1 Billion
Q4 2022 Feb 14, 2023	BUY	$14.85 - $19.04 $48.6 Million - $62.3 Million	3,271,513 New	3,271,513 $53.6 Billion

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Braidwell LP, based on Form 13F filings with the SEC.

Stay updated on Braidwell LP with notifications on news.